Cargando…

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial

BACKGROUND: Herpes zoster and its related complications are associated with significant medical burden, which negatively affects quality of life and daily functioning of the patients. The recently licensed recombinant zoster vaccine (RZV) offers high efficacy but is associated with local and systemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmader, Kenneth E, Levin, Myron J, Grupping, Katrijn, Matthews, Sean, Butuk, David, Chen, Michael, Idrissi, Mohamed El, Fissette, Laurence A, Fogarty, Charles, Hartley, Paul, Klein, Nicola P, Nevarez, Max, Uusinarkaus, Kari, Oostvogels, Lidia, Curran, Desmond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	The Journal of Gerontology: Translational Section
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625580/ https://www.ncbi.nlm.nih.gov/pubmed/30256905 http://dx.doi.org/10.1093/gerona/gly218

Ejemplares similares

2488. The Impact of Reactogenicity After Administration of the Recombinant Zoster Vaccine Upon the Physical Functioning and Quality of Life of Older Adults
por: Schmader, Kenneth E, et al.
Publicado: (2018)

Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults
por: Schmader, Kenneth E, et al.
Publicado: (2020)

2778. Impact of Reactogenicity on Quality of Life and Physical Functioning in Adults ≥50 Years Receiving Both Doses of the Adjuvanted Recombinant Zoster Vaccine
por: Schmader, Kenneth E, et al.
Publicado: (2019)

Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older
por: Curran, Desmond, et al.
Publicado: (2019)

Evaluation of two frailty indices, with practical application in a vaccine clinical trial
por: Curran, Desmond, et al.
Publicado: (2019)

5. How Does Frailty Impact the Efficacy, Reactogenicity, Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine? A Secondary Analysis of the ZOE-50 and ZOE-70 Studies
por: Andrew, Melissa K, et al.
Publicado: (2020)

Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals
por: Curran, Desmond, et al.
Publicado: (2020)

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine
por: Grupping, Katrijn, et al.
Publicado: (2017)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: A Phase III, Group-Matched, Clinical Trial
por: Grupping, Katrijn, et al.
Publicado: (2017)

2780. Reactogenicity Profile of Adjuvanted Recombinant Zoster Vaccine after Dose 2 According to the Intensity of the Same Event Experienced after Dose 1
por: Colindres, Romulo, et al.
Publicado: (2019)

Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials
por: Colindres, Romulo, et al.
Publicado: (2020)

1956. Persistence of Immune Response and Safety of an Adjuvanted Recombinant Zoster Vaccine in Older Adults Previously Vaccinated with a Live-Attenuated Herpes Zoster Vaccine: End-of-Study Results of a Phase III, Group-Matched, Clinical Trial
por: Mrkvan, Tomas, et al.
Publicado: (2018)

Natural History of Herpes Zoster in the Placebo Groups of Three Randomized Phase III Clinical Trials
por: Curran, Desmond, et al.
Publicado: (2022)

The Impact of Volunteering and Its Characteristics on Well-being After State Pension Age: Longitudinal Evidence From the English Longitudinal Study of Ageing
por: Matthews, Katey, et al.
Publicado: (2020)

Sarcopenia Is Negatively Related to High Gravitational Impacts Achieved From Day-to-day Physical Activity
por: Hartley, April, et al.
Publicado: (2018)

Air Pollution Alters Caenorhabditis elegans Development and Lifespan: Responses to Traffic-Related Nanoparticulate Matter
por: Haghani, Amin, et al.
Publicado: (2019)

Assessment of the potential public health impact of Herpes Zoster vaccination in Germany
por: Curran, Desmond, et al.
Publicado: (2017)

A 2-Year Follow-Up After a 2-Year RCT with Vitamin D and Exercise: Effects on Falls, Injurious Falls and Physical Functioning Among Older Women
por: Uusi-Rasi, Kirsti, et al.
Publicado: (2017)

Physical Activity Producing Low, but Not Medium or Higher, Vertical Impacts Is Inversely Related to BMI in Older Adults: Findings From a Multicohort Study
por: Elhakeem, Ahmed, et al.
Publicado: (2018)

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older
por: Schwarz, Tino F, et al.
Publicado: (2017)

Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine
por: Callegaro, Andrea, et al.
Publicado: (2021)

An Analysis of How Herpes Zoster Pain Affects Health-related Quality of Life of Placebo Patients From 3 Randomized Phase III Studies
por: Matthews, Sean, et al.
Publicado: (2023)

26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis
por: Callegaro, Andrea, et al.
Publicado: (2021)

Longitudinal Trajectories of Quality of Life Among People With Mild-to-Moderate Dementia: A Latent Growth Model Approach With IDEAL Cohort Study Data
por: Clare, Linda, et al.
Publicado: (2022)

“Living Well” Trajectories Among Family Caregivers of People With Mild-to-Moderate Dementia in the IDEAL Cohort
por: Clare, Linda, et al.
Publicado: (2022)

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial
por: Godeaux, Olivier, et al.
Publicado: (2017)

Two Functionally Distinct Isoforms of TL1A (TNFSF15) Generated by Differential Ectodomain Shedding
por: Mück, Christoph, et al.
Publicado: (2010)

The Lifestyle Interventions and Independence for Elders Study: Design and Methods
por: Fielding, Roger A., et al.
Publicado: (2011)

Do Positive Psychological Characteristics Modify the Associations of Physical Performance With Functional Decline and Institutionalization? Findings From the Longitudinal Aging Study Amsterdam
por: Cooper, Rachel, et al.
Publicado: (2011)

Surprising SES Gradients in Mortality, Health, and Biomarkers in a Latin American Population of Adults
por: Rosero-Bixby, Luis, et al.
Publicado: (2009)

Prevalence, Awareness, and Management of Hypertension, Dyslipidemia, and Diabetes Among United States Adults Aged 65 and Older
por: McDonald, Margaret, et al.
Publicado: (2009)

Caregiving, Metabolic Syndrome Indicators, and 1-year Decline in Walking Speed: Results of Caregiver-SOF
por: Fredman, Lisa, et al.
Publicado: (2010)

Applications of Cold Temperature Stress to Age Fractionate Caenorhabditis elegans: A Simple Inexpensive Technique
por: Willett, James D., et al.
Publicado: (2010)

Nutritional Geometry Provides Food for Thought
por: Ruth Archer, C., et al.
Publicado: (2009)

Development and Validation of a Video-Animated Tool for Assessing Mobility
por: Rejeski, W. Jack, et al.
Publicado: (2010)

Low Mid-Upper Arm Circumference, Calf Circumference, and Body Mass Index and Mortality in Older Persons
por: Wijnhoven, Hanneke A. H., et al.
Publicado: (2010)

Weight Loss and Self-Regulatory Eating Efficacy in Older Adults: The Cooperative Lifestyle Intervention Program
por: Rejeski, W. Jack, et al.
Publicado: (2011)

Onset and Persistence of Disabling Foot Pain in Community-Dwelling Older Adults Over a 3-Year Period: A Prospective Cohort Study
por: Roddy, Edward, et al.
Publicado: (2011)

Attenuation of Age-Related Metabolic Dysfunction in Mice With a Targeted Disruption of the Cβ Subunit of Protein Kinase A
por: Enns, Linda C., et al.
Publicado: (2009)

How Long Will My Mouse Live? Machine Learning Approaches for Prediction of Mouse Life Span
por: Swindell, William R., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_k6d76kfq75rh3ruf9ieh4uu0oc